Oxford University
Wellington Square
Oxford
OX1 2JD
United Kingdom
Tel: 44-1865-270000
Fax: +44-1865-270708
Website: http://www.ox.ac.uk/
193 articles with Oxford University
-
The U.S. appears to be beating back COVID-19 but it’s still raging in many parts of the world, and studies and trials are still ongoing. Here’s a look at some of today’s top COVID-19 stories.
-
Continuing studies and news about COVID-19 around the world keeps coming in. Here’s a look.
-
Paige, Oxford University and UK NHS Partners Win Government Funding to Evaluate Paige Prostate Cancer Detection System
6/21/2021
Paige, a global leader in AI-based diagnostic software in pathology, announced that the Company, Oxford University and National Health Service regional partners in the United Kingdom have won the prestigious Phase 4 Artificial Intelligence in Health and Care award from the NHS Accelerated Access Collaborative to study Paige Prostate prospectively in a real-world cancer laboratory setting.
-
Oxford University and Oracle Partner to Speed Identification of COVID-19 Variants
5/17/2021
The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants
-
COVID-19 News: Researchers Discover a New Variant, Antiviral Shows Promise in Hamsters and More
4/20/2021
Please check out the biopharma industry's COVID-19 stories that are trending for April 20, 2021. -
In a list of the most innovative companies in 2021, Fast Company has outlined 10 biotech companies that continue to revolutionize the drug-discovery landscape.
-
Medidata and Oxford University Innovation’s Clinical Outcomes Team Announce Addition of Gold Standard Questionnaires to eCOA Library
11/12/2020
Medidata and its customers gain access to pre-configured, pre-approved questionnaires in multiple languages to support clinical study start-up, quality, and efficiency
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 7, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 3, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 22, 2020.
-
Oxford University, which by many standards is ahead of everyone in the vaccine development world, is suggesting end of the year is possible, but being very cautious about it.
-
Clinical Catch-Up: July 13-17
7/20/2020
It was a surprisingly big week for clinical trial updates related to COVID-19, although there was plenty of non-COVID-19 news as well. Here’s a look. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 20, 2020.
-
AstraZeneca’s COVID-19 vaccine candidate induced significant immune responses in the majority of patients following a single dose in a Phase I study. The preventative medication also proved to be fairly safe, study results showed.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.
-
Report: AstraZeneca's COVID-19 Vaccine Generates Antibodies and T-Cells Against the Virus in Phas...
7/16/2020
Phase I data from the COVID-19 vaccine under development by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13 million people across the globe. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 15, 2020.
-
Dexamethasone Reduces Deaths in Hospitalized COVID-19 Patients Needing Oxygen, Study Shows
6/16/2020
Low doses of a long-used steroid known as dexamethasone could be the solution to improving the chances of patients who become seriously ill from COVID-19 infection and require some kind of breathing assistance. -
Less than one month after the White House zeroed in on 14 vaccine candidates for COVID-19, the administration has narrowed that list even more to five potential treatments for the prevention of the novel coronavirus.